
Willie J. Daniel Jr.
Examiner (ID: 12204, Phone: (571)272-7907 , Office: P/2462 )
| Most Active Art Unit | 2462 |
| Art Unit(s) | 2462, 2465, 2641, 2617, 2686 |
| Total Applications | 889 |
| Issued Applications | 433 |
| Pending Applications | 99 |
| Abandoned Applications | 374 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16791559
[patent_doc_number] => 20210121376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => PEPTIDES ENCAPSULATED IN LECITHIN AND ALGINATE
[patent_app_type] => utility
[patent_app_number] => 17/057142
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057142 | PEPTIDES ENCAPSULATED IN LECITHIN AND ALGINATE | May 20, 2019 | Abandoned |
Array
(
[id] => 16686715
[patent_doc_number] => 20210069190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/053605
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053605 | PHARMACEUTICAL COMPOSITION COMPRISING SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREFOR | May 12, 2019 | Abandoned |
Array
(
[id] => 14712779
[patent_doc_number] => 20190247453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => Transdermal Delivery of Cannabidiol with Other Active Moieties Including Cannabinoids
[patent_app_type] => utility
[patent_app_number] => 16/397322
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397322 | Transdermal delivery of cannabidiol with other active moieties including cannabinoids | Apr 28, 2019 | Issued |
Array
(
[id] => 15035311
[patent_doc_number] => 20190328660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => NANOBUBBLES IN AN ABSORBENT MATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/394430
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394430 | NANOBUBBLES IN AN ABSORBENT MATERIAL | Apr 24, 2019 | Abandoned |
Array
(
[id] => 14712485
[patent_doc_number] => 20190247306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/393378
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393378 | ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS | Apr 23, 2019 | Abandoned |
Array
(
[id] => 15020651
[patent_doc_number] => 20190321330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => CANNABIS PLACEBO COMPOSITIONS, DELIVERY VEHICLES AND A METHOD FOR COLOUR MATCHING/NEUTRALIZATION OF CANNABIS PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/388222
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16388222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/388222 | CANNABIS PLACEBO COMPOSITIONS, DELIVERY VEHICLES AND A METHOD FOR COLOUR MATCHING/NEUTRALIZATION OF CANNABIS PRODUCTS | Apr 17, 2019 | Abandoned |
Array
(
[id] => 16612027
[patent_doc_number] => 20210030680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => NANOPARTICLE COMPOSITIONS AND METHODS OF USE OF PARP INHIBITOR FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/733741
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733741 | NANOPARTICLE COMPOSITIONS AND METHODS OF USE OF PARP INHIBITOR FOR TREATMENT OF CANCER | Apr 14, 2019 | Abandoned |
Array
(
[id] => 14682057
[patent_doc_number] => 20190240143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => Sustained Release Pharmaceutical Dosage Form of Entecavir
[patent_app_type] => utility
[patent_app_number] => 16/382921
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382921
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382921 | Sustained Release Pharmaceutical Dosage Form of Entecavir | Apr 11, 2019 | Abandoned |
Array
(
[id] => 16581344
[patent_doc_number] => 20210015746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => NICOTINE GEL
[patent_app_type] => utility
[patent_app_number] => 16/982741
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982741 | NICOTINE GEL | Apr 7, 2019 | Abandoned |
Array
(
[id] => 15586889
[patent_doc_number] => 20200069979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS
[patent_app_type] => utility
[patent_app_number] => 16/377039
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377039 | TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS | Apr 4, 2019 | Abandoned |
Array
(
[id] => 16598184
[patent_doc_number] => 20210024715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => SPHERICAL MICROPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/045691
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045691 | SPHERICAL MICROPARTICLES | Apr 3, 2019 | Abandoned |
Array
(
[id] => 14621437
[patent_doc_number] => 20190224086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => MICROCAPSULE COMPOSITIONS WITH IMPROVED DEPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/371393
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/371393 | MICROCAPSULE COMPOSITIONS WITH IMPROVED DEPOSITION | Mar 31, 2019 | Abandoned |
Array
(
[id] => 16726415
[patent_doc_number] => 20210093562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => ORAL GUM FORMULATION AND FABRICATION PROCESS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/044598
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044598 | ORAL GUM FORMULATION AND FABRICATION PROCESS THEREOF | Mar 28, 2019 | Abandoned |
Array
(
[id] => 14621735
[patent_doc_number] => 20190224235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => TREATMENT OF ENTERIC STRESS FROM HEAT AND INFECTION IN HUMANS AND ANIMALS BY SUPPLEMENTATION WITH ZINC AND BUTYRIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/369844
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16369844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/369844 | TREATMENT OF ENTERIC STRESS FROM HEAT AND INFECTION IN HUMANS AND ANIMALS BY SUPPLEMENTATION WITH ZINC AND BUTYRIC ACID | Mar 28, 2019 | Abandoned |
Array
(
[id] => 16569512
[patent_doc_number] => 20210008518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => PROCESS FOR PREPARING MICROCAPSULES WITH IMPROVED DEPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/979937
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979937 | Process for preparing microcapsules with improved deposition | Mar 24, 2019 | Issued |
Array
(
[id] => 14833285
[patent_doc_number] => 20190275043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/353951
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353951 | SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR | Mar 13, 2019 | Abandoned |
Array
(
[id] => 17821480
[patent_doc_number] => 11426403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 16/351058
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 35735
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16351058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/351058 | Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same | Mar 11, 2019 | Issued |
Array
(
[id] => 14833069
[patent_doc_number] => 20190274935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Antiperspirant/deodorant Composition
[patent_app_type] => utility
[patent_app_number] => 16/299341
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299341 | Antiperspirant/deodorant Composition | Mar 11, 2019 | Abandoned |
Array
(
[id] => 17670770
[patent_doc_number] => 20220183937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHOD FOR IMPROVING THE PERFORMANCE OF A FRAGRANCE OR A FRAGRANCE MIXTURE
[patent_app_type] => utility
[patent_app_number] => 17/438064
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438064 | METHOD FOR IMPROVING THE PERFORMANCE OF A FRAGRANCE OR A FRAGRANCE MIXTURE | Mar 10, 2019 | Abandoned |
Array
(
[id] => 18301043
[patent_doc_number] => 11622928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Organic compounds
[patent_app_type] => utility
[patent_app_number] => 16/971758
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8917
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971758 | Organic compounds | Mar 6, 2019 | Issued |